Direct Cost of Parkinson’s Disease: A Real-World Data Study of Second-Line Therapies

Table 1

Patients treated with DBS from 2016 to 2018.

Year	2016	2017	2018
Neurostimulator device implantation	16 patients	19 patients	18 patients
Battery replacement	0 patients	5 patients	2 patients